FOSUN HEALTH Logo

Vestibular Schwannoma Treatment

catalogue

Vestibular Schwannoma Treatment

Vestibular Schwannoma Treatment

There are three main options, and the choice between them depends on the size of the tumour, whether it is growing, what the hearing on the affected side is doing, and the patient's own priorities. A small tumour that is not growing is usually observed with scheduled scans. A tumour that is growing, or causing trouble beyond the ear, is treated — with a single precisely aimed session of radiation for small and medium tumours, or with microsurgical removal through an approach chosen by size and by what is to be protected.

How the decision is made

Four findings decide which of the options applies, and they are weighed together rather than one at a time:

  • Is it growing? For a tumour causing little, growth measured between two scans is the single most influential finding — and the reason observation always comes with a schedule rather than an open-ended wait.
  • How large is it? A tumour contained in the canal keeps every option open; one that compresses the brainstem has moved past the question of whether to treat to the question of how.
  • What is the hearing doing? Hearing that is still useful changes what is worth attempting, and hearing that is already lost on that side removes the reason to choose one approach over another for the sake of preservation.
  • What matters to the patient? Age, other conditions, and what the patient is willing to trade — a higher chance of no further treatment against a higher chance of side effects, or the risk of an operation against years of scheduled scans — belong in the decision and should be asked about explicitly.

Two principles follow. The first is that doing nothing for now is a treatment decision rather than a failure to decide — it is chosen when the tumour is behaving quietly, and it is reviewed at defined intervals. The second is that the plan is revisited as the tumour and the hearing change, because a tumour watched for years may cross from one category into another, and what was right at one point is not necessarily right later.

Observation with scans at intervals

A vestibular schwannoma is one of the few tumours where waiting and watching is an established option, and understanding why makes it easier to accept or to question:

  • Which tumours are observed — small tumours causing little, that are not growing on successive scans. This commonly includes tumours found incidentally and tumours whose symptoms are stable.
  • What the schedule looks like — MRI at defined intervals, more frequent at first and widening if the tumour proves quiet, with the dates given in writing and each scan compared with the previous study. Hearing tests travel with the scans, since the hearing can change even when the size does not.
  • What would end the observation — growth on the scan, a change in the hearing beyond what the tumour was already doing, or the appearance of new symptoms such as facial numbness.
  • Why it is reasonable rather than a delay — because many of these tumours never grow measurably, and because every active treatment in this canal carries real risks to the facial nerve and the hearing that are not worth taking for a tumour that is doing nothing.
  • What still has to be done while observing — keeping the schedule, reporting new symptoms between scans, and making sure one centre holds the images, since a comparison cannot be made from a report alone.

Precisely aimed radiation

Stereotactic radiosurgery is the option that has changed this condition most in recent decades, and how it works determines what it can and cannot achieve:

  • What it is — a single session of radiation, delivered with the head held exactly still in a frame or a mask, shaped precisely to the tumour and stopping short of the surrounding tissue. No incision is made, and the session itself is not painful.
  • What it aims to do — stop the tumour growing. The tumour usually does not disappear; the measure of success is stability on successive scans over years, sometimes with slow shrinkage.
  • Which tumours it suits — small and medium tumours, whether treated primarily or chosen after growth during observation. It is also used for a tumour that has grown again after an operation.
  • What it asks in return — the radiation is permanent, and its effects on the hearing and the facial nerve unfold over the following years; the hearing may drift down over time, and the facial nerve is almost always protected but the risk is not zero.
  • What follows — scheduled MRI and hearing tests at defined intervals for years, since the outcome is written in the follow-up rather than in the session itself.

Surgery: removing the tumour

Microsurgery removes the tumour, and the approach is chosen by the size of the tumour and by what is to be protected:

  • Retrosigmoid approach — from behind the ear, the approach that offers the best chance of preserving hearing that is still useful, used for small and medium tumours with worth-saving hearing.
  • Translabyrinthine approach — through the inner ear itself, which means accepting the loss of hearing on that side as the price of the approach, chosen for larger tumours or where the hearing is already gone and the exposure it gives is the best.
  • Middle fossa approach — from above, used selectively for small tumours contained in or at the inner end of the canal, with the aim of preserving both hearing and facial function.
  • What is monitored throughout — the facial nerve, continuously, with electrodes that warn the surgeon of its position; the aim is complete removal with an intact face, and the monitoring is what makes that aim realistic.
  • What is reported afterwards — the completeness of removal, the facial function on a formal scale, and the hearing, all measured rather than described.
  • What surgery offers that radiation does not — the tumour is gone, the result is known immediately rather than over years, and tissue has been obtained; what it costs is the operation itself, with its recovery and its risks.

Hearing, honestly framed

Hearing is the question patients care about most, and it deserves a direct account rather than a hopeful one:

  • The hearing is often already affected by the time the tumour is found, and no treatment restores what has been lost — the goal is preserving what remains, not recovering what is gone.
  • What predicts preservation — chiefly two things: how much hearing there was to begin with, and how small the tumour is. Both are known before the choice is made, which is why the audiogram belongs in the decision.
  • What each pathway offers — observation leaves the hearing as the tumour finds it; radiation aims to keep the hearing that remains while stopping growth; hearing-preserving surgery offers the chance of keeping useful hearing at the cost of an operation.
  • Rehabilitation when hearing is lost — hearing aids, devices that route sound from the affected side to the better ear, and, in selected patients, cochlear implantation. These are real options with real results, worth discussing rather than resigning from.
  • Tinnitus — often persists independently of the treatment chosen, and has its own management: sound therapy, hearing devices that mask it, and the strategies taught in tinnitus programmes.

Balance, the face and everyday life

Part of the treatment is directed at what the tumour and its treatment cause rather than at the tumour itself:

  • Vestibular rehabilitation — a structured programme of exercises that retrains the balance system, accelerating the compensation the brain performs naturally; it is prescribed rather than improvised, and it works best when started deliberately.
  • Facial exercises and support where facial function has been affected, guided by specialists in facial rehabilitation, since recovery of movement benefits from practice rather than patience alone.
  • Management of facial numbness — attention to the eye that may be less protected when sensation is reduced, and practical advice about eating and shaving on the numb side.
  • Driving and work — decided by the balance, the hearing and the seizure-free record rather than by the diagnosis; the questions deserve explicit answers rather than inference.
  • The psychological load — living with a tumour in the head, whether watched or treated, is real, and the support for it is part of the treatment rather than an admission.

How the plan is made and reviewed

The decision here sits between more specialties than most tumours of this size, and it is best made once rather than in sequence:

  • Neurosurgery assesses what an operation could achieve and protect, and which approach fits the anatomy.
  • Radiation oncology assesses whether radiosurgery is the better option, and plans the dose and the shape of the treatment.
  • Audiology measures the hearing on both sides, establishes the baseline, and conducts the follow-up that measures what was kept.
  • Neurotology and rehabilitation contribute on the balance, the tinnitus and the hearing devices that belong to every pathway.
  • Genetics contributes in the situations that suggest an inherited condition, before the follow-up plan is fixed.
  • One written plan, with dates, listing what is being done, what each step is for, what would change the plan, and who to contact between reviews — because this is a condition followed over years.

Frequently Asked Questions

Is it safe to wait and watch a vestibular schwannoma?

For a small tumour causing little, that is a legitimate and commonly recommended approach rather than a delay — provided the observation has a schedule. Many of these tumours never grow measurably, and every active treatment in this canal carries real risks that are not worth taking for a tumour that is quiet. What makes observation safe is that the intervals are defined and in writing, that growth between scans triggers a reassessment, and that new symptoms are reported rather than waited out. A decision to observe should leave you knowing when the next scan is and what would end the watching.

How do I choose between radiosurgery and surgery?

By the same three findings that shape everything else. Radiosurgery suits small and medium tumours and asks nothing of the body in the way an operation does — but it aims to stop growth rather than to remove it, its results unfold over years, and the radiation is permanent. Surgery removes the tumour and settles the question immediately, at the cost of an operation with its own risks to the face and the hearing. Where the hearing is still useful and the tumour is small, both pathways remain open, and the patient's own weighting — a session of radiation and years of scans, or an operation and a known result — is a legitimate part of the answer.

Will treatment bring my hearing back?

No treatment restores hearing that has been lost, and this is worth hearing plainly: the goal of every pathway is preserving what remains, not recovering what is gone. That is why the audiogram is taken before treatment and repeated after it, and why hearing that is still useful changes what is worth attempting. Where the hearing has been lost or cannot be kept, rehabilitation — hearing aids, devices that route sound to the better ear, and in selected patients cochlear implantation — offers real function, and discussing it is not giving up but planning.

What if the tumour grows again after treatment?

There is usually a defined next step. A tumour that grows during observation moves to treatment, and every option is usually still open at that point. A tumour that grows again after radiosurgery is reassessed carefully: a further session of radiation may be possible, or surgery may be offered, and the choice depends on when the growth appeared, how much the tumour enlarged, and what the hearing and the facial nerve are doing. A tumour that recurs after an operation can be treated with radiation or re-operated on. What matters is that the follow-up is close enough to catch the growth while the options are still open.

Send the imaging and audiograms, get the options set out

Upload the MRI images and reports with dates — every scan, not only the latest — the audiograms on both sides, the operative or radiotherapy record if treatment has been given, and the current medication. Our neurosurgery, radiation oncology and audiology team will return a written assessment within 48 hours of the file being complete.

Want to see the whole process first? Your full medical journey, step by step →

Book an Appointment Request a Video Consultation

Follow Fosun Health

Apply for an Appointment

Do you have test results*